PTC · Investment summary · as of 30 July 2026
Priced close to what the business has demonstrated
Business type: Compounder · mature and structurally stable
At $136.29, PTC requires a 6% five-year revenue growth rate to justify its enterprise value — less than the business already delivers, at 9%.
The value rests on an exit multiple of 15.1x and a terminal operating margin of 34%. Move any one of them materially and the conclusion moves with it, which is why the required-versus-demonstrated test above carries more weight here than the point value.
The strongest argument against this view: Cause: the ASC 606 cohort that inflated FY2025 does not repeat, and FY2027 laps it.
| Question | Evidence-based conclusion |
|---|---|
| What drives the business? | Not determined — the operating driver is not stated in one place |
| What do we forecast? | Revenue growth of 9% demonstrated; a terminal operating margin of 34%; an exit multiple of 15.1x. |
| What does Street forecast? | Not determined — no consensus estimates are joined to this record |
| Where do we differ? | On revenue growth, the difference between what the price requires and what the business has demonstrated is +3.6 percentage points. |
| What is it worth? | Twelve-month target $132.59, -3% from the struck price. Scenario-weighted expected return net of costs -2.7%. |
| Why now? | Date not announced — no dated event that would resolve the disagreement is on file |
Not determined — no falsifiable operating conditions are on file for this name, so the thesis cannot be reduced to a small number of testable claims
Date not announced — no dated event that would resolve the disagreement is on file
Cause: the ASC 606 cohort that inflated FY2025 does not repeat, and FY2027 laps it. FY2025 revenue grew 19% and operating margin +1030bp on "higher total value and longer average duration of contracts that commenced in the current year." Long-duration contracts recognised upfront do not recur until they renew. FY2026 is already guiding revenue −2% to 0% against that base. If FY2027 contract duration mean-reverts further while ARR compounds at 9%, reported revenue can fall again even as the business grows — and the market, which prices PTC on a 15.05x trailing EV/EBIT that was built on a $1,117
Not determined — no falsifiable invalidation conditions are on file, so this position cannot be risk-monitored
On approach to the $132.59 target the case is reviewed rather than added to; a target reached is a reason to re-examine the position, not to hold it by default. The position is trimmed once forward expected return falls below 0% net of costs, because the capital has a better use elsewhere in the book.
| Criteria | Status | Investment meaning |
|---|---|---|
| Quality | Met | Is the business worth owning under its declared economic type? |
| Valuation | Met | Is the operating path required by today's price achievable? |
| Liquidity | Not determined | Can the intended position be built and exited in the right vehicle? Not established on the evidence on file. |
| Downside | Met | Cause: the ASC 606 cohort that inflated FY2025 does not repeat, and FY2027 laps it. |
| Momentum | Not determined | Does price action support or complicate entry timing? Not established on the evidence on file. |
| Catalyst | Not determined | Is there a dated event that resolves the disagreement? Not established on the evidence on file. |
| Consensus | Not determined | Is the house-versus-Street disagreement identified and quantified? Not established on the evidence on file. |
Quality, valuation and liquidity can prevent a position on their own. The remaining four inform timing, sizing and monitoring, and never reject an investment by themselves.
The strongest case for mispricing is that the business already delivers +3.6 percentage points more growth than the price requires. The most important unresolved uncertainty is whether a position could be built and exited at the intended size. The next evidence that should change the portfolio decision is the next scheduled results, or a daily close below $119.94, which forces an immediate review.